glp 1 agonist how does it work Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Patient education tips for GLP-1,

The researchers compared the one-year risk of HF hospitalization or death in new users of each GLP-1 drug to the risk of those outcomes in a placebo group of patients taking sitagliptin, a diabetes drug known to have no impact on HFpEF

Declarations Ethics approval and consent to participate Not applicable

Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes

Read the full study: Helen Michaela de Oliveira MS, Mariano Reynaldo Gallo Ruelas RD, Pandora Eloa Oliveira Fonseca MS, Camilo Andr Viana Diaz MS, Guilherme Oliveira de Paula MS, Pablo Ramon Fruett da Costa MD, Tariq Parker MD, PhD, Kristopher T

However, many studies fail to establish a causative relationship between treatment and symptoms, suggesting that GLP-1 RAs have a favorable safety profile

Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of alzheimers disease